IP Library › Assignment 071247/0836

Patent Assignment

Reel/Frame 071247/0836

Security Interest

Recorded: 2025-05-09 Pages: 88

View PDF Order Certified Copy

Assignors

AXSOME THERAPEUTICS, INC.

Executed: 2025-05-08

AXSOME MALTA LTD.

Executed: 2025-05-08

Assignee

WILMINGTON TRUST, NATIONAL ASSOCIATION

50 SOUTH SIXTH STREET, SUITE 1290, MINNEAPOLIS, MINNESOTA, 55402

Covered Properties (351)

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2016/026991 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2018/012433 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2018/032162 ↗

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

PCT: PCT/US2019/019445 ↗

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

PCT: PCT/US2019/036406 ↗

Compositions for Delivery of Reboxetine

PCT: PCT/US2019/037500 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2019/040495 ↗

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

PCT: PCT/US2019/052210 ↗

Dosage Forms Comprising Active Pharmaceutical Ingredients

PCT: PCT/US2019/053167 ↗

Use of Reboxetine to Treat Narcolepsy

PCT: PCT/US2019/056134 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2020/017046 ↗

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

PCT: PCT/US2020/046755 ↗

Use of Reboxetine to Treat Nervous System Disorders

PCT: PCT/US2020/062560 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2021/065552 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2023/067172 ↗

Pharmaceutical Compositions Comprising Bupropion and Cysteine

PCT: PCT/US2023/069239 ↗

Microparticles Containing Bupropion

PCT: PCT/US2023/069367 ↗

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

PCT: PCT/US2023/074790 ↗

Use of Mazindol to Treat Nervous System Disorders

PCT: PCT/US2023/076145 ↗

Compositions and Methods for Treating Insomnia

PCT: PCT/US2023/078928 ↗

Methods and Compositions for Improving Driving Performance

PCT: PCT/US2023/081798 ↗

Methods of Administering Solriamfetol to Lactating Women

PCT: PCT/US2023/086351 ↗

Methods and Compositions for Treating Cognitive Impairment in a Subject with Impaired Cognition Associated with Obstructive Sleep Apnea and Excessive Daytime Sleepiness

PCT: PCT/US2024/031557 ↗

Solriamfetol for the Treatment of Certain Neurological Conditions

PCT: PCT/US2024/034397 ↗

Methods of Administering Solriamfetol to Lactating Women

PCT: PCT/US2024/036129 ↗

Use of Solriamfetol for the Treatment of Orphan Diseases

PCT: PCT/US2024/043181 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2024/044700 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2024/047114 ↗

Solriamfetol for Improving Cognitive Health in Apnea Patients

PCT: PCT/US2024/047294 ↗

Compounds and Combinations Thereof for Treating Depression in Patients

PCT: PCT/US2024/058092 ↗

Use of Esreboxetine to Treat Nervous System Disorders

PCT: PCT/US2025/012527 ↗

Use of Reboxetine to Treat Narcolepsy

PCT: PCT/US2025/021386 ↗

Pharmaceutical Compositions Comprising Meloxicam

PCT: PCT/US2025/023660 ↗

Treatment of Cataplexy

Patent: 9,359,290 →

Application: 14/205,423 →

Publication: US 2014/0275244

Treatment for Obesity

Patent: 9,226,910 →

Application: 14/334,694 →

Publication: US 2015/0025136

Treatment for Obesity

Patent: 9,649,291 →

Application: 14/955,646 →

Publication: US 2016/0081970

Pharmaceutical Compositions Comprising Meloxicam

Patent: 9,821,075 →

Application: 15/132,130 →

Publication: US 2016/0228576

Treatment of Cataplexy

Patent: 9,585,863 →

Application: 15/149,478 →

Publication: US 2016/0250176

Treatment of Cataplexy

Patent: 10,259,780 →

Application: 15/419,133 →

Publication: US 2017/0137375

Treatment for Obesity

Patent: 10,105,341 →

Application: 15/594,070 →

Publication: US 2017/0340596

Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate

Patent: 10,195,151 →

Application: 15/695,913 →

Publication: US 2018/0064652

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,058,614 →

Application: 15/797,955 →

Publication: US 2018/0050106

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,029,010 →

Application: 15/902,770 →

Publication: US 2018/0207274

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,137,131 →

Application: 15/936,176 →

Publication: US 2018/0214380

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,471,068 →

Application: 15/976,800 →

Publication: US 2018/0256593

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,265,399 →

Application: 15/984,055 →

Publication: US 2018/0264114

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,195,278 →

Application: 15/986,215 →

Publication: US 2019/0000975

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,265,400 →

Application: 15/988,104 →

Publication: US 2018/0264115

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,195,279 →

Application: 15/989,734 →

Publication: US 2018/0271981

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,307,484 →

Application: 16/000,701 →

Publication: US 2018/0280512

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,471,014 →

Application: 16/001,697 →

Publication: US 2018/0280306

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,583,088 →

Application: 16/002,865 →

Publication: US 2018/0280308

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,463,736 →

Application: 16/006,548 →

Publication: US 2018/0289806

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,369,224 →

Application: 16/006,642 →

Publication: US 2018/0289807

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,369,225 →

Application: 16/006,692 →

Publication: US 2018/0289808

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,265,324 →

Application: 16/181,086 →

Publication: US 2019/0070192

Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate

Patent: 10,512,609 →

Application: 16/225,890 →

Publication: US 2019/0117578

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,322,181 →

Application: 16/247,406 →

Publication: US 2019/0142942

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,363,312 →

Application: 16/248,449 →

Publication: US 2019/0142943

Solvate Form of (R)-2-amino-3-phenylpropyl carbamate

Patent: 10,829,443 →

Application: 16/331,069 →

Publication: US 2019/0194126

Carbamoyl Phenylalaninol Compounds and Uses Thereof

Patent: 10,710,958 →

Application: 16/338,925 →

Publication: US 2019/0218175

Treatment of Cataplexy

Patent: 11,072,579 →

Application: 16/359,446 →

Publication: US 2019/0218174

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 16/362,434 →

Publication: US 2020/0093760

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 16/364,005 →

Publication: US 2019/0216800

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 16/364,463 →

Publication: US 2019/0216801

Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases

Application: 16/365,459 →

Publication: US 2019/0216728

Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases

Application: 16/366,207 →

Publication: US 2019/0216832

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,485,871 →

Application: 16/372,958 →

Publication: US 2019/0224320

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,426,839 →

Application: 16/372,977 →

Publication: US 2019/0224321

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,471,069 →

Application: 16/374,081 →

Publication: US 2019/0231792

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,456,471 →

Application: 16/403,034 →

Publication: US 2019/0255177

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,512,692 →

Application: 16/440,695 →

Publication: US 2019/0307884

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,512,693 →

Application: 16/454,319 →

Publication: US 2019/0314504

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 16/513,367 →

Publication: US 2019/0374521

Combination Treatment for Migraine and Other Pain

Patent: 10,688,102 →

Application: 16/513,612 →

Publication: US 2019/0336510

Compositions for Delivery of Reboxetine

Application: 16/514,948 →

Publication: US 2019/0381056

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,532,101 →

Application: 16/565,111 →

Publication: US 2020/0000919

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,537,642 →

Application: 16/566,476 →

Publication: US 2020/0000920

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,517,950 →

Application: 16/567,859 →

Publication: US 2020/0000921

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,729,696 →

Application: 16/568,703 →

Publication: US 2020/0000819

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,722,583 →

Application: 16/570,434 →

Publication: US 2020/0000922

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,729,697 →

Application: 16/570,451 →

Publication: US 2020/0000820

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,729,773 →

Application: 16/572,042 →

Publication: US 2020/0009250

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 10,695,304 →

Application: 16/579,305 →

Publication: US 2020/0093761

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,561,664 →

Application: 16/589,692 →

Publication: US 2020/0030338

Methods and Compositions for Treating Excessive Sleepiness

Patent: 10,959,976 →

Application: 16/618,735 →

Publication: US 2020/0163927

Carbamoyl Phenylalaninol Analogs and Uses Thereof

Patent: 11,413,264 →

Application: 16/634,935 →

Publication: US 2021/0093603

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,583,144 →

Application: 16/653,877 →

Publication: US 2020/0038408

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,653,777 →

Application: 16/688,491 →

Publication: US 2020/0085951

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,688,185 →

Application: 16/689,970 →

Publication: US 2020/0085952

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,695,429 →

Application: 16/690,464 →

Publication: US 2020/0085953

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,695,430 →

Application: 16/693,052 →

Publication: US 2020/0085954

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,702,602 →

Application: 16/694,440 →

Publication: US 2020/0085955

Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia

Application: 16/740,329 →

Publication: US 2020/0147093

Use of Reboxetine to Treat Narcolepsy

Patent: 11,351,175 →

Application: 16/740,409 →

Publication: US 2020/0147094

Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia

Application: 16/740,410 →

Publication: US 2020/0147095

Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia

Application: 16/740,411 →

Publication: US 2020/0147096

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,702,535 →

Application: 16/773,567 →

Publication: US 2020/0155565

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,266,657 →

Application: 16/790,085 →

Publication: US 2020/0179396

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,344,513 →

Application: 16/806,145 →

Publication: US 2020/0197331

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,344,514 →

Application: 16/807,512 →

Publication: US 2020/0197333

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 10,940,133 →

Application: 16/824,560 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 16/830,637 →

Publication: US 2020/0222339

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,331,285 →

Application: 16/832,153 →

Publication: US 2020/0222342

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,729,774 →

Application: 16/834,077 →

Publication: US 2020/0222539

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,758,617 →

Application: 16/835,848 →

Publication: US 2020/0230239

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,780,165 →

Application: 16/837,769 →

Publication: US 2020/0230240

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,821,181 →

Application: 16/841,436 →

Publication: US 2020/0230241

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,799,588 →

Application: 16/842,063 →

Publication: US 2020/0246461

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,758,618 →

Application: 16/843,490 →

Publication: US 2020/0246462

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,780,166 →

Application: 16/844,634 →

Publication: US 2020/0254097

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,894,053 →

Application: 16/854,320 →

Publication: US 2020/0261466

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,987,358 →

Application: 16/857,435 →

Publication: US 2020/0261467

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,821,182 →

Application: 16/867,929 →

Publication: US 2020/0276311

Methods and Compositions for Treating Excessive Sleepiness

Patent: 10,912,754 →

Application: 16/877,717 →

Publication: US 2020/0281886

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,940,153 →

Application: 16/885,975 →

Publication: US 2020/0289524

Carbamoyl Phenylalaninol Compounds and Uses Thereof

Patent: 11,149,000 →

Application: 16/891,464 →

Publication: US 2020/0290955

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,433,035 →

Application: 16/907,691 →

Publication: US 2020/0315992

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,905,693 →

Application: 16/921,006 →

Publication: US 2020/0330476

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,179,351 →

Application: 16/923,420 →

Publication: US 2020/0338021

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,179,352 →

Application: 16/924,510 →

Publication: US 2020/0345664

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,933,136 →

Application: 16/927,623 →

Publication: US 2020/0338198

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 16/931,907 →

Publication: US 2020/0345663

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,918,722 →

Application: 16/997,740 →

Publication: US 2020/0376124

Pharmaceutical Compositions Comprising Meloxicam

Patent: 10,933,137 →

Application: 16/998,622 →

Publication: US 2020/0376125

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,013,805 →

Application: 17/016,172 →

Publication: US 2020/0405861

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,013,806 →

Application: 17/018,275 →

Publication: US 2020/0405862

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,045,549 →

Application: 17/021,131 →

Publication: US 2021/0008211

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,020,483 →

Application: 17/024,233 →

Publication: US 2021/0000956

Treatment for Obesity

Patent: 11,497,725 →

Application: 17/028,674 →

Publication: US 2021/0077450

Compositions for Delivery of Reboxetine

Application: 17/064,016 →

Publication: US 2021/0015823

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,110,173 →

Application: 17/067,006 →

Publication: US 2021/0030876

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Patent: 11,560,354 →

Application: 17/091,222 →

Publication: US 2021/0053912

Use of Reboxetine to Treat Narcolepsy

Application: 17/116,874 →

Publication: US 2021/0100808

Use of Reboxetine to Treat Narcolepsy

Patent: 11,020,402 →

Application: 17/119,792 →

Publication: US 2021/0100809

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,219,626 →

Application: 17/122,618 →

Publication: US 2021/0121474

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,207,327 →

Application: 17/145,744 →

Publication: US 2021/0128575

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,077,117 →

Application: 17/148,342 →

Publication: US 2021/0128576

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,160,779 →

Application: 17/149,406 →

Publication: US 2021/0290589

Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate

Patent: 11,439,597 →

Application: 17/154,336 →

Publication: US 2021/0205227

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 17/158,464 →

Publication: US 2021/0145770

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,129,895 →

Application: 17/165,274 →

Publication: US 2021/0154299

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,135,295 →

Application: 17/168,016 →

Publication: US 2021/0177971

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,123,431 →

Application: 17/170,453 →

Publication: US 2021/0177972

Use of Reboxetine to Treat Narcolepsy

Patent: 11,135,226 →

Application: 17/177,554 →

Publication: US 2021/0169893

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 17/183,645 →

Publication: US 2021/0196704

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,207,328 →

Application: 17/183,700 →

Publication: US 2021/0196726

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 17/187,454 →

Publication: US 2021/0177834

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,185,550 →

Application: 17/205,936 →

Publication: US 2021/0228592

Methods and Compositions for Treating Excessive Sleepiness

Patent: 11,648,232 →

Application: 17/212,079 →

Publication: US 2021/0205257

Use of Reboxetine to Treat Narcolepsy

Patent: 11,185,547 →

Application: 17/245,644 →

Publication: US 2021/0252007

Dosage Forms Comprising Active Pharmaceutical Ingredients

Application: 17/280,379 →

Publication: US 2023/0285306

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,291,639 →

Application: 17/305,195 →

Publication: US 2021/0330613

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,285,213 →

Application: 17/318,691 →

Publication: US 2021/0260193

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,285,214 →

Application: 17/319,898 →

Publication: US 2021/0260194

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,285,215 →

Application: 17/325,616 →

Publication: US 2021/0275670

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,357,854 →

Application: 17/360,574 →

Publication: US 2021/0322552

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,426,414 →

Application: 17/381,771 →

Publication: US 2021/0346393

Treatment of Cataplexy

Patent: 11,713,292 →

Application: 17/383,707 →

Publication: US 2022/0017457

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,331,323 →

Application: 17/388,805 →

Publication: US 2021/0353636

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,571,428 →

Application: 17/392,456 →

Publication: US 2021/0361667

Use of Reboxetine to Treat Narcolepsy

Patent: 11,364,245 →

Application: 17/398,368 →

Publication: US 2021/0369722

Pharmaceutical Compositions Comprising Meloxicam

Application: 17/402,252 →

Publication: US 2021/0369845

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,471,464 →

Application: 17/404,129 →

Publication: US 2021/0369729

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,369,684 →

Application: 17/466,623 →

Publication: US 2021/0393782

Pharmaceutical Compositions Comprising Meloxicam

Application: 17/469,539 →

Publication: US 2021/0401988

Carbamoyl Phenylalaninol Compounds and Uses Thereof

Patent: 11,780,805 →

Application: 17/470,063 →

Publication: US 2022/0098145

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 12,318,362 →

Application: 17/479,121 →

Publication: US 2022/0000831

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,504,429 →

Application: 17/484,875 →

Publication: US 2022/0008539

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 17/496,460 →

Publication: US 2022/0023234

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,510,927 →

Application: 17/517,223 →

Publication: US 2022/0054498

Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia

Application: 17/536,669 →

Publication: US 2022/0249501

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,433,078 →

Application: 17/544,365 →

Publication: US 2022/0088027

Pharmaceutical Compositions Comprising Meloxicam

Application: 17/547,676 →

Publication: US 2022/0096490

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,433,079 →

Application: 17/549,081 →

Publication: US 2022/0105104

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,617,791 →

Application: 17/656,602 →

Publication: US 2022/0211851

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,471,465 →

Application: 17/657,546 →

Publication: US 2022/0218718

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,617,755 →

Application: 17/677,906 →

Publication: US 2022/0175792

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,607,456 →

Application: 17/678,495 →

Publication: US 2022/0175927

Pharmaceutical Compositions Comprising Meloxicam

Application: 17/680,926 →

Publication: US 2022/0233698

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,786,488 →

Application: 17/692,068 →

Publication: US 2022/0193011

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 17/692,090 →

Publication: US 2022/0193009

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,617,756 →

Application: 17/723,771 →

Publication: US 2022/0241292

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,660,273 →

Application: 17/728,554 →

Publication: US 2022/0257538

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 17/730,015 →

Publication: US 2022/0249405

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 11,660,274 →

Application: 17/731,247 →

Publication: US 2022/0249406

Reboxetine to Treat Narcolepsy

Patent: 11,883,408 →

Application: 17/751,490 →

Publication: US 2022/0280524

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,738,085 →

Application: 17/809,151 →

Publication: US 2022/0331428

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,602,563 →

Application: 17/837,790 →

Publication: US 2022/0313824

Use of Reboxetine to Treat Narcolepsy

Patent: 12,115,165 →

Application: 17/845,767 →

Publication: US 2022/0362252

Compositions for Delivery of Reboxetine

Patent: 11,957,686 →

Application: 17/848,685 →

Publication: US 2022/0313699

Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate

Patent: 11,998,639 →

Application: 17/929,396 →

Publication: US 2023/0078754

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,801,250 →

Application: 17/929,631 →

Publication: US 2023/0000879

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,806,354 →

Application: 17/929,633 →

Publication: US 2023/0000880

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,712,441 →

Application: 17/930,272 →

Publication: US 2023/0016504

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,759,522 →

Application: 17/933,703 →

Publication: US 2023/0025944

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,628,173 →

Application: 17/934,244 →

Publication: US 2023/0042938

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,865,117 →

Application: 18/051,656 →

Publication: US 2023/0097899

Treatment for Obesity

Patent: 12,201,601 →

Application: 18/055,017 →

Publication: US 2023/0172896

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,826,370 →

Application: 18/062,729 →

Publication: US 2023/0108797

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/065,013 →

Publication: US 2023/0131057

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Patent: 12,384,743 →

Application: 18/066,000 →

Publication: US 2023/0183172

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,771,666 →

Application: 18/148,682 →

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 18/153,950 →

Publication: US 2024/0238273

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,005,118 →

Application: 18/159,232 →

Publication: US 2023/0173072

Microparticles Containing Bupropion

Application: 18/162,259 →

Publication: US 2024/0000729

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,771,667 →

Application: 18/176,816 →

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,793,776 →

Application: 18/176,855 →

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,779,554 →

Application: 18/176,860 →

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,944,683 →

Application: 18/185,477 →

Publication: US 2023/0218762

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,826,354 →

Application: 18/192,245 →

Publication: US 2023/0233574

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,839,598 →

Application: 18/194,491 →

Publication: US 2023/0285351

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,850,226 →

Application: 18/194,496 →

Publication: US 2023/0233507

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,839,599 →

Application: 18/194,498 →

Publication: US 2023/0233508

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,850,227 →

Application: 18/194,503 →

Publication: US 2023/0248686

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,850,228 →

Application: 18/295,114 →

Publication: US 2023/0263764

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,969,404 →

Application: 18/295,138 →

Publication: US 2023/0310362

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,986,455 →

Application: 18/295,146 →

Publication: US 2023/0233509

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 18/299,009 →

Publication: US 2024/0358696

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 18/300,318 →

Publication: US 2023/0248668

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 18/300,917 →

Publication: US 2023/0248669

Methods and Compositions for Treating Excessive Sleepiness

Patent: 11,865,098 →

Application: 18/316,841 →

Publication: US 2024/0033243

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/323,040 →

Publication: US 2023/0372355

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,064,411 →

Application: 18/323,229 →

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,872,203 →

Application: 18/323,232 →

Methods of Administering Solriamfetol to Lactating Women

Patent: 11,872,204 →

Application: 18/323,236 →

Treatment of Cataplexy

Patent: 12,162,821 →

Application: 18/337,299 →

Publication: US 2023/0416195

Pharmaceutical Compositions Comprising Meloxicam

Patent: 11,998,552 →

Application: 18/337,552 →

Publication: US 2023/0338390

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,986,454 →

Application: 18/340,005 →

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 11,857,528 →

Application: 18/340,006 →

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,370,196 →

Application: 18/347,970 →

Publication: US 2023/0355637

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/366,992 →

Publication: US 2024/0197887

Use of Reboxetine to Treat Narcolepsy

Patent: 12,246,023 →

Application: 18/389,771 →

Publication: US 2024/0131031

Combination Dosage Forms and Administration Thereof

Application: 18/415,561 →

Publication: US 2025/0228845

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Patent: 12,102,606 →

Application: 18/461,389 →

Publication: US 2023/0414538

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/489,685 →

Publication: US 2024/0058354

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,005,036 →

Application: 18/491,291 →

Publication: US 2024/0216300

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,036,194 →

Application: 18/491,301 →

Publication: US 2024/0216301

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,090,126 →

Application: 18/491,311 →

Publication: US 2024/0216302

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,102,609 →

Application: 18/491,319 →

Publication: US 2024/0216303

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,128,052 →

Application: 18/493,178 →

Publication: US 2024/0066036

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/503,996 →

Publication: US 2024/0082254

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/510,986 →

Publication: US 2024/0100060

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/512,551 →

Publication: US 2024/0091236

Microparticles Containing Bupropion

Application: 18/512,632 →

Publication: US 2025/0161239

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,472,255 →

Application: 18/582,561 →

Publication: US 2024/0245776

Compositions for Delivery of Reboxetine

Application: 18/599,109 →

Publication: US 2025/0064820

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Patent: 12,194,016 →

Application: 18/627,708 →

Publication: US 2024/0252462

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/636,093 →

Publication: US 2024/0261407

Formulations of (R)-2-Amino-3-Phenylpropyl Carbamate

Patent: 12,390,419 →

Application: 18/643,086 →

Publication: US 2024/0285538

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 18/650,022 →

Publication: US 2024/0293342

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 18/650,053 →

Publication: US 2024/0277635

Use of Reboxetine to Treat Narcolepsy

Application: 18/671,931 →

Publication: US 2024/0307407

Pharmaceutical Compositions Comprising a Tolfenamic Acid

Patent: 12,268,693 →

Application: 18/674,761 →

Publication: US 2024/0307408

Methods and Compisitions for Ameliorating Biomarkers Associated with Cardiovascualr Risk Using (R)-2-Amino-3-Phenylpropyl Carbamate

Application: 18/687,962 →

Publication: US 2024/0358668

Methods and Compositions for Treating Cognitive Impairment

Application: 18/712,835 →

Publication: US 2025/0032442

Methods of Administering Solriamfetol to Lactating Women

Application: 18/758,658 →

Publication: US 2024/0350435

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 18/813,008 →

Publication: US 2025/0127732

Methods of Administering Solriamfetol to Lactating Women

Application: 18/819,015 →

Publication: US 2025/0000825

Use of Reboxetine to Treat Narcolepsy

Application: 18/820,232 →

Publication: US 2024/0415842

Use of Reboxetine to Treat Narcolepsy

Application: 18/827,622 →

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,357,640 →

Application: 18/895,044 →

Publication: US 2025/0009754

Carbamoyl Phenylalaninol Analogs and Uses Thereof

Application: 18/901,040 →

Publication: US 2025/0017890

Pharmaceutical Compositions Comprising Bupropion and Cysteine

Patent: 12,357,697 →

Application: 18/921,291 →

Publication: US 2025/0041426

Methods of Administering Solriamfetol to Lactating Women

Patent: 12,263,145 →

Application: 18/926,907 →

Publication: US 2025/0041251

Treatment of Cataplexy

Application: 18/935,803 →

Publication: US 2025/0059135

Carbamoyl Phenylalaninol Compounds and Uses Thereof

Application: 18/937,105 →

Publication: US 2025/0059136

Pharmaceutical Compositions Comprising Meloxicam

Application: 18/950,743 →

Publication: US 2025/0195534

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Application: 18/977,224 →

Publication: US 2025/0108030

Methods and Compositions for Treating Excessive Sleepiness

Application: 18/983,605 →

Publication: US 2025/0114322

Pharmaceutical Compositions Comprising Bupropion and Cysteine

Application: 18/984,644 →

Publication: US 2025/0248952

Microparticles Containing Bupropion

Application: 18/988,215 →

Publication: US 2025/0235414

Methods of Providing Solriamfetol Therapy to Subjects with Impaired Renal Function

Application: 19/019,748 →

Publication: US 2025/0152548

Use of Reboxetine to Treat Narcolepsy

Patent: 12,447,155 →

Application: 19/024,709 →

Publication: US 2025/0161316

Pharmaceutical Compositions Comprising Meloxicam

Application: 19/030,296 →

Publication: US 2025/0205246

Pharmaceutical Compositions Comprising Meloxicam

Patent: 12,485,176 →

Application: 19/050,993 →

Publication: US 2025/0177535

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 19/065,198 →

Publication: US 2025/0195465

Methods of Treating Migraines with a Combination of a Meloxicam and a Rizatriptan

Patent: 12,544,383 →

Application: 19/075,007 →

Use of Mazindol to Treat Nervous System Disorders

Application: 19/077,364 →

Publication: US 2025/0360107

Pharmaceutical Compositions Comprising Meloxicam

Application: 19/085,084 →

Publication: US 2026/0027127

(S)-2-((S)-(2-Ethoxyphenoxy)(Phenyl)Methyl)-4-Nitrosomorpholine

Patent: 12,565,478 →

Application: 19/096,247 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 19/169,261 →

Publication: US 2025/0255880

Pharmaceutical Compositions Comprising Meloxicam

Application: 19/181,172 →

Publication: US 2026/0000677

Pharmaceutical Compositions Comprising Meloxicam and Cyclodextrins

Application: 62/114,215 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/259,993 →

Pharmaceutical Compositions Comprising Frovatriptan

Application: 62/442,136 →

Pharmaceutical Compositions Comprising Frovatriptan

Application: 62/504,105 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/526,884 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/536,466 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/634,718 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/680,956 →

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 62/682,998 →

Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion

Application: 62/683,399 →

Compositions for Delivery of Reboxetine

Application: 62/686,075 →

Compositions for Delivery of Reboxetine

Application: 62/688,333 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/693,871 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/734,021 →

Dosage Forms Comprising Active Pharmaceutical Ingredients

Application: 62/738,833 →

Compositions for Delivery of Reboxetine

Application: 62/745,956 →

Combination of Dextromethorphan and Bupropion for Treating Depression

Application: 62/789,431 →

Combination of Dextromethorphan and Bupropion for Treating Depression

Application: 62/789,446 →

Combination of Dextromethorphan and Bupropion for Treating Depression

Application: 62/789,451 →

Combination of Dextromethorphan and Bupropion for Treating Depression

Application: 62/789,488 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/794,469 →

Neridronic Acid and Other Bisphosphonates for Treating Complex Regional Pain Syndrome and Other Diseases

Application: 62/802,107 →

Meloxicam and Rizatriptan for Treating Migraine

Application: 62/802,198 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/803,756 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/809,480 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/810,880 →

Combination Treatment for Migraine and Other Pain

Application: 62/835,613 →

Compositions for Delivery of Reboxetine

Application: 62/837,002 →

Dosage Forms Comprising Active Pharmaceutical Ingredients

Application: 62/842,394 →

Combination Treatment for Migraine and Other Pain

Application: 62/846,311 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 62/860,705 →

Combination of Meloxicam and Rizatriptan with Improved Pharmacokinetics

Application: 62/895,933 →

Combination of Meloxicam and Rizatriptan with Improved Pharmacokinetics

Application: 62/895,956 →

Use of Reboxetine to Treat Narcolepsy

Application: 62/943,077 →

Use of Reboxetine to Treat Narcolepsy

Application: 62/946,295 →

Combination treatment for migraine and other pain

Application: 62/955,905 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/971,174 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/978,626 →

Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion

Application: 62/992,060 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/133,125 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/343,982 →

Pharmaceutical Compositions Comprising Bupropion and Cysteine

Application: 63/357,318 →

Microparticles Containing Bupropion

Application: 63/357,355 →

Pharmaceutical Compositions Comprising Bupropion and Cysteine

Application: 63/370,554 →

Microparticles Containing Bupropion

Application: 63/370,572 →

Pharmaceutical Compositions Comprising Bupropion and Cysteine

Application: 63/370,777 →

Microparticles Containing Bupropion

Application: 63/370,778 →

Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions

Application: 63/376,585 →

Use of Mazindol to Treat Nervous System Disorders

Application: 63/378,490 →

Solriamfetol for Treating Adults with Adhd

Application: 63/508,847 →

Use of Reboxetine to Treat Narcolepsy

Application: 63/569,684 →

Use of Reboxetine to Treat Narcolepsy

Application: 63/573,409 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/579,833 →

Solriamfetol for the Treatment of Adhd

Application: 63/582,340 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/583,473 →

Solriamfetol for Improving Cognitive Health in Apnea Patients

Application: 63/583,552 →

Solriamfetol for the Treatment of Adhd

Application: 63/588,966 →

Compounds and Combinations Thereof for Treating Depression in Patients with Reduced Interest-Activity

Application: 63/605,337 →

Compounds and Combinations Thereof for Treating Depression in Patients

Application: 63/605,408 →

Solriamfetol for the Treatment of Certain Neurological Conditions

Application: 63/607,505 →

Solriamfetol for the Treatment of Certain Neurological Conditions

Application: 63/607,536 →

Solriamfetol for Improving Cognitive Health in Apnea Patients

Application: 63/613,710 →

Use of Reboxetine to Treat Nervous System Disorders

Application: 63/623,678 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/634,452 →

Polymorph Forms of Reboxetine

Application: 63/738,431 →

(S)-2-((S)-(2-Ethoxyphenoxy)(Phenyl)Methyl)-4-Nitrosomorpholine

Application: 63/747,812 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/751,707 →

Pharmaceutical Compositions Comprising Meloxicam

Application: 63/751,735 →

Related Assignments (25)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Jul 29, 2014

From: KHAYRALLAH, MOISE A.; BREAM, GARY; BUTTS, STEPHEN E.

To: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; SK BIOPHARMACEUTICALS CO., LTD.

Reel/Frame 033414/0487 →

Assignment of Assignor's Interest Apr 7, 2015

From: KHAYRALLAH, MOISE A.; BREAM, GARY; BUTTS, STEPHEN E.

To: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; SK BIOPHARMACEUTICALS CO., LTD.

Reel/Frame 035350/0091 →

Security Agreement Jun 19, 2015

From: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED

To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT

Reel/Frame 035936/0200 →

Assignment of Assignor's Interest Jun 24, 2016

From: TABUTEAU, HERRIOT

To: ANTICEP BIOVENTURES II LLC

Reel/Frame 039005/0001 →

Corrective Assignment to Correct the Spelling of the Assignee's Name on the Coversheet Previously Recorded at Reel: 039005 Frame: 0001. Assignor(S) Hereby Confirms the Assignment. Jun 29, 2016

From: TABUTEAU, HERRIOT

To: ANTECIP BIOVENTURES II LLC

Reel/Frame 039206/0481 →

Corrective Assignment to Correct the Spelling of the Receiving Party Name Previously Recorded on Reel 039005 Frame 0001. Assignor(S) Hereby Confirms the Assignment. Jul 19, 2016

From: TABUTEAU, HERRIOT

To: ANTECIP BIOVENTURES II LLC

Reel/Frame 039391/0585 →

Assignment of Assignor's Interest Sep 21, 2017

From: ANTECIP BIOVENTURES II LLC

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 043657/0690 →

Assignment of Assignor's Interest Dec 8, 2017

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 044343/0453 →

Assignment of Assignor's Interest May 21, 2018

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 045865/0715 →

Assignment of Assignor's Interest May 21, 2018

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 045865/0404 →

Assignment of Assignor's Interest Feb 28, 2019

From: TABUTEAU, HERRIOT

To: ANTECIP BIOVENTURES II LLC

Reel/Frame 048465/0210 →

Assignment of Assignor's Interest Feb 28, 2019

From: ANTECIP BIOVENTURES II LLC

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 048472/0333 →

Assignment of Assignor's Interest Jul 3, 2019

From: JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED

To: JAZZ PHARMACEUTICALS IRELAND LIMITED

Reel/Frame 049666/0456 →

Assignment of Assignor's Interest Oct 3, 2019

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 050618/0971 →

Assignment of Assignor's Interest Nov 5, 2019

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 050922/0607 →

Assignment of Assignor's Interest Nov 5, 2019

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 050923/0223 →

Assignment of Assignor's Interest Mar 11, 2020

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 052089/0385 →

Assignment of Assignor's Interest Mar 12, 2020

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 052102/0337 →

Assignment of Assignor's Interest Sep 21, 2020

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 053835/0359 →

Intellectual Property Security Agreement Sep 25, 2020

From: AXSOME THERAPEUTICS, INC.

To: HERCULES CAPITAL, INC., AS AGENT

Reel/Frame 053941/0491 →

Assignment of Assignor's Interest Nov 30, 2020

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 054491/0425 →

Assignment of Assignor's Interest Feb 9, 2021

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 055189/0097 →

Security Agreement May 5, 2021

From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.

To: U.S. BANK NATIONAL ASSOCIATION

Reel/Frame 056151/0010 →

Release of Security Interest May 5, 2021

From: BANK OF AMERICA, N.A.

To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED

Reel/Frame 056150/0708 →

Assignment of Assignor's Interest Jan 11, 2022

From: TABUTEAU, HERRIOT

To: AXSOME THERAPEUTICS, INC.

Reel/Frame 058621/0906 →